Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Aarti Pharmalabs LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:543748NSE Symbol: AARTIPHARMP/E(TTM):31.34
ISIN Demat:INE0LRU01027Div & Yield %:0.56EPS(TTM):28.39
Book Value(Rs):203.4396162Market Cap ( Cr.):8064.22Face Value(Rs):5
    Change Company 
Chairman (Non-Executive)Rashesh C Gogri
Vice Chairperson & MDHetal Gogri Gala
Managing DirectorNarendra Jagannath Salvi
Non Executive DirectorRajendra V Gogri
Parimal H Desai
Independent DirectorBhavesh R Vora
Vinay Gopal Nayak
Vilas G Gaikar
Jeenal Savla
Rupal Vora
Pradeep Thakur
Company Sec. & Compli. OfficerJeevan Mondkar
Chairman EmeritusC V Gogri
Non Executive DirectorNEHAL GAREWAL